Medical Xpress news

Medical Xpress / Glioblastoma mapping uncovers four recurring tumor cell communities, revealing treatment targets

Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this type of cancer is often resistant to available treatments is that it is characterized by a highly diverse ...

Apr 29, 2026
Medical Xpress / New autism therapy may improve children's social communication in just five days

A new non-invasive brain stimulation technique known as accelerated continuous theta burst stimulation (a-cTBS) improves social communication at one month follow-up and has a favorable safety profile in children with autism, ...

Apr 29, 2026
Medical Xpress / Scientists recruit red blood cells to deliver genetic cargo with instructions to kill cancer

Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from the body—by using red blood cells to deliver genetic instructions. Current CAR (chimeric antigen receptor) ...

Apr 29, 2026
Medical Xpress / A natural molecule boosts CAR-T therapy and turns cold tumors hot

CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR-T regulatory T cells (CAR-Tregs), which weaken immune responses. Therefore, selectively targeting ...

Apr 29, 2026
Medical Xpress / How the architecture of the prefrontal cortex shapes our creativity

When a writer comes up with a striking metaphor, when an engineer solves a tricky problem by combining seemingly unrelated tools, or when a child invents the rules of a new game, what happens in the brain? In cognitive neuroscience, ...

Apr 29, 2026
Medical Xpress / Swimming beats running for strengthening the heart, study finds

A study conducted on an animal model by researchers at the Federal University of São Paulo (UNIFESP) in Brazil demonstrated that swimming is more effective than running in promoting healthy heart growth and improving the ...

Apr 29, 2026
Medical Xpress / Autonomous AI renews 192 drugs in Utah pilot, exposing safety and legal gaps

A first-of-its-kind pilot program in Utah developed by a health-technology startup company uses artificial intelligence to automatically renew certain prescriptions for patients with chronic conditions such as hypertension ...

Apr 29, 2026
Medical Xpress / Handheld TB test delivers lab-level accuracy in under 30 minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer. A big obstacle has been testing. It's either inaccurate—missing up to half of all cases—or requires ...

Apr 29, 2026
Medical Xpress / One molecule, two effects: A new drug concept to treat obesity and type 2 diabetes

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...

Apr 29, 2026
Medical Xpress / New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only two treatment regimens available with limited efficacy. Pancreatic cancers do not respond to immunotherapy ...

Apr 29, 2026
Medical Xpress / Molecular switch guides neurons through developing brain, revealing opposing migration pathways

During brain development, neurons can regulate their movement until they reach their final destination thanks to a "molecular switch" involving the protein Teneurin 4 (Ten4). This protein can guide neuronal migration through ...

Apr 29, 2026
Medical Xpress / 'Click clotting' stops bleeding fast and could transform emergency care

Researchers at McGill University have developed a rapid way to engineer blood clots that stop severe bleeding and support tissue healing more effectively. Their technique, called "click clotting," links red blood cell surface ...

Apr 29, 2026